Invention Grant
- Patent Title: Combination cancer immunotherapy with pentaaza macrocyclic ring complex
-
Application No.: US16604872Application Date: 2018-04-13
-
Publication No.: US11246950B2Publication Date: 2022-02-15
- Inventor: Robert A. Beardsley , Jeffery L. Keene , Dennis P. Riley
- Applicant: Galera Labs, LLC
- Applicant Address: US MO Creve Coeur
- Assignee: Galera Labs, LLC
- Current Assignee: Galera Labs, LLC
- Current Assignee Address: US MO Creve Coeur
- Agency: Bryan Cave Leighton Paisner LLP
- International Application: PCT/US2018/027588 WO 20180413
- International Announcement: WO2018/191676 WO 20181018
- Main IPC: A61K51/04
- IPC: A61K51/04 ; A61P35/00 ; A61K35/17 ; A61K39/00 ; A61K39/395

Abstract:
A method of treating a cancer in a mammalian subject afflicted with the cancer, includes administering to the subject an immune checkpoint inhibitor, and administering to the subject a pentaaza macrocyclic ring complex corresponding to the formula (I) below, prior to, concomitantly with, or after administration of the immune checkpoint inhibitor, to increase the response of the cancer to the immune checkpoint inhibitor.
Public/Granted literature
- US20200376148A1 COMBINATION CANCER IMMUNOTHERAPY WITH PENTAAZA MACROCYCLIC RING COMPLEX Public/Granted day:2020-12-03
Information query